Ftse Mib
33.167,64
-0,78%
DAX
19.295,98
-0,59%
S&P 500
6.021,63
0,57%
NASDAQ
19.175,58
0,63%
Bitcoin
92.698,47
0,79%
Pepperstone
Advertisement
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni Europa EU Innate Pharma (IPH) Innate Pharma (IPH) Notizie

IPH

Innate Pharma (IPH)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:EU:IPH
DataOraFonteTitoloSimboloCompagnia
19/12/202313:38MF Dow Jones (Italiano)Le azioni di Innate Pharma salgono dopo l'esercizio dell'opzione dilicenza da parte di SanofiEU:IPHInnate Pharma
19/12/202313:28Dow Jones NewsInnate Pharma Shares Rise after Sanofi Exercises Licensing OptionEU:IPHInnate Pharma
19/12/202308:39Dow Jones NewsSanofi exerce une option de licence en oncologie auprès d'Innate PharmaEU:IPHInnate Pharma
05/10/202314:14Dow Jones NewsInnate Pharma Shares Fall Premarket on FDA Partial Study HoldEU:IPHInnate Pharma
08/06/202316:53Dow Jones NewsInnate Pharma Shares Rise 8% After Cancer Treatment Gets Fast Track DesignationEU:IPHInnate Pharma
19/12/202208:25Dow Jones NewsSanofi et Innate Pharma étendent leur collaboration en oncologie avec les cellules NKEU:IPHInnate Pharma
01/08/202212:30Dow Jones NewsInnate Pharma Shares Slide After Failure of Monalizumab in Head, Neck CancerEU:IPHInnate Pharma
23/09/202107:00GlobeNewswire Inc.Nouveau nombre d'actions et de droits de vote d'Innate Pharma au 1er septembre 2021EU:IPHInnate Pharma
23/09/202107:00GlobeNewswire Inc.Number of Shares and Voting Rights of Innate Pharma as of September 1, 2021EU:IPHInnate Pharma
17/09/202113:45GlobeNewswire Inc.Monalizumab Data From COAST Trial Presented at ESMO Congress 2021EU:IPHInnate Pharma
17/09/202113:45GlobeNewswire Inc.Présentation de Données Issues de l'Essai COAST Comprenant Monalizumab au Congrès de l'ESMO 2021EU:IPHInnate Pharma
17/09/202113:45GlobeNewswire Inc.Monalizumab Data from COAST Trial Presented at ESMO Congress 2021EU:IPHInnate Pharma
15/09/202107:00GlobeNewswire Inc.Innate Pharma reports first half 2021 financial results and business updateEU:IPHInnate Pharma
15/09/202107:00GlobeNewswire Inc.Innate Pharma présente ses résultats financiers et l'avancée de son portefeuille au premier semestre 2021EU:IPHInnate Pharma
15/09/202107:00GlobeNewswire Inc.Rapport Financier Semestriel 30 juin 2021EU:IPHInnate Pharma
15/09/202107:00GlobeNewswire Inc.Innate Pharma Reports First Half 2021 Financial Results and Business UpdateEU:IPHInnate Pharma
07/09/202107:00GlobeNewswire Inc.Innate Pharma Organise une Conférence Téléphonique et un Webcast pour ses Résultats Financiers au Premier Semestre 2021EU:IPHInnate Pharma
07/09/202107:00GlobeNewswire Inc.Innate Pharma Announces Conference Call and Webcast for First Half 2021 Business UpdateEU:IPHInnate Pharma
02/09/202108:00GlobeNewswire Inc.Monalizumab and ANKET™ Data Will Be Presented at ESMO 2021 Virtual CongressEU:IPHInnate Pharma
02/09/202108:00GlobeNewswire Inc.Des données sur monalizumab et ANKET™ seront présentées au congrès virtuel de l’ESMO 2021EU:IPHInnate Pharma
02/09/202108:00GlobeNewswire Inc.Monalizumab and ANKET™ Data Will be Presented at ESMO 2021 Virtual CongressEU:IPHInnate Pharma
30/08/202107:00GlobeNewswire Inc.Innate Pharma to Participate in Upcoming Investor ConferencesEU:IPHInnate Pharma
30/08/202107:00GlobeNewswire Inc.Prochains Rendez-Vous Investisseurs d'Innate PharmaEU:IPHInnate Pharma
11/08/202107:00GlobeNewswire Inc.Number of Shares and Voting Rights of Innate Pharma as of August 1, 2021EU:IPHInnate Pharma
11/08/202107:00GlobeNewswire Inc.Nouveau Nombre d'Actions et de Droits de Vote d'Innate Pharma au 1er Aout 2021EU:IPHInnate Pharma
12/07/202107:00GlobeNewswire Inc.NUMBER OF SHARES AND VOTING RIGHTS OF INNATE PHARMA AS OF JULY 1, 2021EU:IPHInnate Pharma
12/07/202107:00GlobeNewswire Inc.Nouveau Nombre d'Actions et de Droits de Vote d'Innate Pharma au 1er Juillet 2021EU:IPHInnate Pharma
12/07/202107:00GlobeNewswire Inc.Number of Shares and Voting Rights of Innate Pharma as of July 1, 2021EU:IPHInnate Pharma
06/07/202107:00GlobeNewswire Inc.Update on Avdoralimab Phase 2 Force Trial in COVID-19 Patients With Severe PneumoniaEU:IPHInnate Pharma
06/07/202107:00GlobeNewswire Inc.Update on Avdoralimab Phase 2 FORCE Trial in COVID-19 Patients with Severe PneumoniaEU:IPHInnate Pharma
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:EU:IPH

La tua Cronologia

BIT
UCG
Unicredit
BIT
STLAM
Stellantis NV
BIT
BAMI
Banco BPM
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
ISP
Intesa Sanpaolo
BIT
ENI
Eni
BIT
ENEL
Enel
BIT
STMMI
ST Microelectronics
BIT
MONC
Moncler
BIT
SPM
Saipem
BIT
G
Generali
BIT
CPR
Davide Campari
BIT
RACE
Ferrari NV
BIT
BPE
Bper Banca
BIT
TEN
Tenaris
BIT
PIRC
Pirelli & C
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network